Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 10/06/2020.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques fabriquées localement :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE Rapport |
1 | RIVAROXABAN TERIAK | RIVAROXABAN | 10 mg | Comprimé pelliculé | B/10 | TERIAK | E | N | 12/05/2020 |
2 | RIVAROXABAN TERIAK | RIVAROXABAN | 10 mg | Comprimé pelliculé | B/30 | TERIAK | E | N | 12/05/2020 |
3 | RIVAROXABAN TERIAK | RIVAROXABAN | 15 mg | Comprimé pelliculé | B/40 | TERIAK | E | N | 12/05/2020 |
4 | RIVAROXABAN TERIAK | RIVAROXABAN | 20 mg | Comprimé pelliculé | B/10 | TERIAK | E | N | 12/05/2020 |
5 | RIVAROXABAN TERIAK | RIVAROXABAN | 20 mg | Comprimé pelliculé | B/30 | TERIAK | E | N | 12/05/2020 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE Rapport |
1 | SMACTYL | DIOSMECTITE | 3 g | Poudre pour suspension orale | B/12 sachets | PHARMAGHREB | I | N | - - |
Spécialités Pharmaceutiques importées :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | INLYTA | AXITINIB | 5 mg | COMP PEL | B/28 | PFIZER AG | V | N | 20/11/2019 |
2 | INLYTA | AXITINIB | 5 mg | COMP PEL | B/56 | PFIZER AG | V | N | 20/11/2019 |
3 | INLYTA | AXITINIB | 1 mg | COMP PEL | B/56 | PFIZER AG | V | N | 20/11/2019 |
4 | INLYTA | AXITINIB | 1 mg | COMP PEL | B/28 | PFIZER AG | V | N | 20/11/2019 |
5 | TOT'HEMA | CUIVRE+MANGANESE+FER | 0.7mg/1.33mg/50mg | SOL BUV | B/20AMP/10ml | INNOTECH INTERNATIONAL | E | N | 26/11/2019 |
6 | DEXAFREE | DEXAMETHASONE | 1 mg/ml | COLLYRE MONODOSE | B/30 unidoses/0.4 ml | THEA | E | N | 28/11/2019 |
7 | PRILIGY | DAPOXETINE | 30 mg | COMP PEL | B/3 | MENARINI Ind.Farmaceutiche Riunite SRL | C | N | 18/12/2019 |
8 | PRILIGY | DAPOXETINE | 60 mg | COMP PEL | B/3 | MENARINI Ind.Farmaceutiche Riunite SRL | C | N | 18/12/2019 |
9 | MIRVASO | BRIMONIDINE | 3MG/GR | GEL DERMIQUE | Tube/30gr | GALDERMA INTERNATIONAL | C | N | 27/12/2019 |
10 | EYLEA | AFLIBERCEPT | 40 mg/ml | SOL INJ | FL/ 100 ml | BAYER AG Leverkusen | N | 30/12/2019 | |
11 | SUPRANE | DESFLURANE | 100% | LIQUIDE VOLATIL | B/ 6 FL/240ML | BAXTER HEALTHCARE | V | N | 24/02/2020 |
12 | SEVOFLURANE USP | SEVOFLURANE | 100% | LIQUIDE VOLATIL | B/ 6 FL/250ML | BAXTER HEALTHCARE | V | N | 24/02/2020 |
13 | SEVOFLURANE USP | SEVOFLURANE | 100% | LIQUIDE PR INHA | B/1FL /250ML | PIRAMAL CRITICAL CARE INC | V | N | 24/02/2020 |
14 | BUTRANS | BUPRENORPHINE | 5ug/h | Dispositif transdermique | B/4 Patchs | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
15 | BUTRANS | BUPRENORPHINE | 10ug/h | Dispositif transdermique | B/4 Patchs | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
16 | BUTRANS | BUPRENORPHINE | 20ug/h | Dispositif transdermique | B/4 Patchs | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
17 | OXYNORM | OXYCODONE | 10mg/ml | SOL INJ | B/5/1ml | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
18 | OXYNORM | OXYCODONE | 20mg/ml | SOL INJ | B/5/2ml | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
19 | OXYCONTIN | OXYCODONE | 10mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
20 | OXYCONTIN | OXYCODONE | 15mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
21 | OXYCONTIN | OXYCODONE | 20mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
22 | OXYCONTIN | OXYCODONE | 30mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
23 | OXYCONTIN | OXYCODONE | 40mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
24 | RAPAMUNE | SIROLIMUS | 1mg | cp enrobé | B/30 | PFIZER Europe MA EEIG | E | N | 13/04/2020 |
25 | CANCIDAS | CASPOFUNGINE | 50mg | Poudre pour prep injectable | B/1 | MSD | E | N | 17/04/2020 |
26 | CANCIDAS | CASPOFUNGINE | 70mg | Poudre pour prep injectable | B/1 | MSD | E | N | 17/04/2020 |
27 | PRADAXA | DABIGATRAN | 150 mg | GELULE | B/60 | BOEHRINGER ING.INT.GmbH | E | N | 11/05/2020 |
28 | PRADAXA | DABIGATRAN | 110 mg | GELULE | B/30 | BOEHRINGER ING.INT.GmbH | E | V | 11/05/2020 |
29 | PRADAXA | DABIGATRAN | 110 mg | GELULE | B/60 | BOEHRINGER ING.INT.GmbH | E | V | 11/05/2020 |
30 | ZYTIGA | ABIRATERONE | 500 mg | CP PEL | B/56 | Janssen-Cilag International N.V | V | N | 12/05/2020 |
31 | ZYTIGA | ABIRATERONE | 250 mg | CP PEL | B/120 | Janssen-Cilag International N.V | V | V | 12/05/2020 |
32 | HERCEPTIN SOUS-CUTANE | TRASTUZUMAB | 600mg | SOL INJ | FL/5ml | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | V | N | 19/05/2020 |
33 | ACIDE ZOLEDRONIQUE MYLAN | ACIDE ZOLÉDRONIQUE | 4 MG/5 ML | SOL INJ | B/ 1FL/ 5ml | MYLAN S.A.S | E | N | 22/05/2020 |
34 | ZELBORAF | VEMURAFENIB | 240 mg | CP PEL | B/56 | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | V | N | 28/05/2020 |
35 | FASLODEX | FLUVESTRANT | 250 mg | SOL INJ | B/2/5ML | ASTRA ZENECA | V | V | 02/06/2020 |
36 | TOUJEO | INSULINE GLARGINE | 300unités/ml | SOL INJ | B/3 Stylos | SANOFI-AVENTIS Deutschland GmbH | V | N | 02/06/2020 |
37 | CYCLOGEST | PROGESTERONE | 200 MG | OVULE | B/15 | L.D.Collins & Co.ltd | E | N | 05/06/2020 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | IMBRUVICA | IBRUTINIB | 140 MG | GELULE | B/90 | Janssen-Cilag International N.V | E | V | CS 03/12/2019 |
2 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/7 | ABBVIE ltd | N | CS 03/12/2019 | |
3 | VENCLYXTO | VENETOCLAX | 50 mg | COMP PEL | B/7 | ABBVIE ltd | N | CS 03/12/2019 | |
4 | VENCLYXTO | VENETOCLAX | 10 mg | COMP PEL | B/14 | ABBVIE ltd | N | CS 03/12/2019 | |
5 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/14 | ABBVIE ltd | N | CS 03/12/2019 | |
6 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/112 | ABBVIE ltd | N | CS 03/12/2019 | |
7 | ZIAGEN | ABACAVIR | 300 mg | COMP PEL | B/60 | ViiV Healthcare BV | E | N | Transfert 04/12/2019 |
8 | VIAGRA | SILDENAFIL | 25 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 09/12/2019 |
9 | VIAGRA | SILDENAFIL | 50 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 16/12/2019 |
10 | VIAGRA | SILDENAFIL | 100 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 16/12/2019 |
11 | INVANZ | ERTAPENEM | 1 GR | PDRE PR PREP INJ | B/1F/15ML | Merck Sharp & Dohme Ltd R.U | E | N | CS 20/12/2019 |
12 | RIFOCINE | RIFAMYCINE | 250 MG | SOL INJ | B/1FL/3ML | SANOFI AVENTIS SPA | E | V | CS 20/12/2019 |
13 | PREVENAR 13 | VACCIN PNEUMOCOCCIQUE | NA | SUSP INJ | B/1seringue pré-remplie/0.5ml | PFIZER Europe MA EEIG | I | N | TRANSFERT 20/12/2019 |
14 | SOLICARE | SOLIFENACINE SUCCINATE | 5 mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 20/12/2019 |
15 | SOLICARE | SOLIFENACINE SUCCINATE | 10 mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 20/12/2019 |
16 | RILUZOLE MYLAN 50 | RILUZOLE | 50 mg | COMP PEL | B/56 | MYLAN S.A.S | E | N | 24/12/2019 |
17 | DUPHASTON | DYDROGESTERONE | 10 MG | COMP | B/10 | Abbott B.V | E | N | TRANSFERT 25/12/2019 |
18 | RHESONATIV | IMMUNOGLOBUNE HUMAINE ANTI D | 625 UI/ML | SOL INJ | B/1/2ML | OCTAPHARMA | E | V | 25/12/2019 |
19 | KETODERM 2% GEL EN SACHET | KETOCONAZOLE | 2% | GEL DERMIQUE | B/8/6 GR | EG LABO - Laboratoires Eurogenerics SAS | E | N | TRANSFERT 31/12/2019 |
20 | XOLAIR | OMALIZUMAB | 150 mg | PDRE PR SOL INJ | B/1F | NOVARTIS PHARMA AG | V | CS 06/01/2020 | |
21 | BRICANYL LP | TERBUTALINE | 5 MG | COMP LP | FL/60 | ASTRA ZENECA | E | V | CS 06/01/2020 |
22 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | CS 06/01/2020 |
23 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/60 | Bristol-Myers Squibb/Pfizr EEIG | E | N | CS 06/01/2020 |
24 | ELIQUIS | APIXABAN | 2,5MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT CS 06/01/2020 |
25 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT CS 06/01/2020 |
26 | SUXAMETHONIUM-LABESFAL | SUXAMETHONIUM | 100 MG/2ML | SOL INJ | B/100/2ML | LABESFAL | V | V | CS 06/01/2020 |
27 | DESLORATADINE GENEPHARM | DESLORATADINE | 5 MG | COMP | B/30 | GENEPHARM S.A | E | N | 15/01/2020 |
28 | DESLORATADINE GENEPHARM | DESLORATADINE | 2,5 MG | COMP | B/30 | GENEPHARM S.A | E | N | 15/01/2020 |
29 | LEVONORGESTREL MYLAN | LEVONORGESTREL | 1.5 mg | COMP | B/1 | MYLAN S.A.S | E | N | 15/01/2020 |
30 | VAXIGRIP | VACCIN ANTIGRIPPE | SUSP INJ | B/1SER/0,5 ML | SANOFI PASTEUR SA | I | V | CS 17/01/2020 | |
31 | JADENU | DEFERASIROX | 360MG | COMP PEL | B/30 | NOVARTIS PHARMA SCHWEIZ AG | V | N | 22/01/2020 |
32 | JADENU | DEFERASIROX | 180MG | COMP PEL | B/90 | NOVARTIS PHARMA | V | N | 22/01/2020 |
33 | JADENU | DEFERASIROX | 90MG | COMP PEL | B/90 | NOVARTIS PHARMA | V | N | 22/01/2020 |
34 | VESOMNI | SOLIFENACINE+ TAMSULOSINE | 6mg/0.4mg | COMP | B/30 | ASTELLAS PHARMA EUROPE B.V HOLLANDE | N | 22/01/2020 | |
35 | TOMEC | DORZOLAMIDE+ TIMOLOL | 100 mg/ 25mg | COLLYRE | FL/5 ml | ABDI IBRAHIM IIac San. ve Tic. A.S. | E | N | 22/01/2020 |
36 | OFNOL | OLOPATADINE | 0.1% | COLLYRE | FL/5 ml | ABDI IBRAHIM IIac San. ve Tic. A.S. | E | N | 04/02/2020 |
37 | ORAP | PIMOZIDE | 4 MG | COMP | B/30 | EUMEDICA PHARMACEUTICALS GmbH | E | N | TRANSFERT 04/02/2020 |
38 | LYRICA | PREGABALINE | 75 mg | GEL | B/56 | PFIZER Europe MA EEIG | V | N | TRANSFERT 04/02/2020 |
39 | LYRICA | PREGABALINE | 75 mg | GEL | B/56 | PFIZER Europe MA EEIG | V | N | TRANSFERT 04/02/2020 |
40 | LYRICA | PREGABALINE | 150 mg | GEL | B/14 | PFIZER Europe MA EEIG | V | N | TRANSFERT 04/02/2020 |
41 | ALECENSA | ALECTINIB | 150 MG | GELULE | B/224 | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | N | 10/02/2020 | |
42 | NOCDURNA | DESMOPRESSINE | 50 µg | LYOPHI ORAL | B/30 | FERRING ARZNEIMITTEL GmbH | E | N | 17/02/2020 |
43 | NOCDURNA | DESMOPRESSINE | 25 µg | LYOPHI ORAL | B/30 | FERRING ARZNEIMITTEL GmbH | E | N | 17/02/2020 |
44 | TOBREX | TOBRAMYCINE | 0.3% | pommade ophtalmo | Tube/3.5 gr | NOVARTIS PHARMA SCHWEIZ AG | E | N | 17/02/2020 |
45 | TOBRADEX | DEXAMETHASONE+ TOBRAMYCINE | 100 mg/300 mg | COLLYRE | FL/5 ml | NOVARTIS PHARMA SCHWEIZ AG | E | N | 17/02/2020 |
46 | DIPIPERON | PIPAMPERONE | 40 MG | COMP | B/20 | EUMEDICA PHARMACEUTICALS GmbH | E | N | Transfert 19/02/2020 |
47 | COSENTYX | SECUKINUMAB | 150MG/ML | SOL INJ | B/2 seringues pré_remplis | NOVARTIS EUROPHARM LIMITED IRLANDE | E | N | Transfert 21/02/2020 |
48 | COSENTYX | SECUKINUMAB | 150MG/ML | SOL INJ | B/2 Stylos pré_remplis | NOVARTIS EUROPHARM LIMITED IRLANDE | E | N | Transfert 21/02/2020 |
49 | ENBREL | ETANERCEPT | 50 mg | SOL INJ | B/4 stylos pré-remplis | PFIZER Europe MA EEIG | E | N | Transfert 21/02/2020 |
50 | ENBREL | ETANERCEPT | 25 mg | SOL INJ | B/4 seringues pré-remplis | PFIZER Europe MA EEIG | E | N | Transfert 21/02/2020 |
51 | PERJETA | PERTUZUMAB | 450 MG | SOL INJ | B/1 | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | E | V | CS 12/03/2020 |
52 | STOCRIN | EFAVIRENZ | 30mg/ml | SOL BUVABLE | B/ 01 flacon de 180 ml | MSD PAYS BAS | V | N | 16/04/2020 |
53 | PROGESTAN | PROGESTERONE | 100 MG | CAPSULE MOLLE | B/30 | BESINS INTERNATIONAL | E | N | RE 07/05/2020 |
54 | PROGESTAN | PROGESTERONE | 200 MG | CAPSULE MOLLE | B/15 | BESINS INTERNATIONAL | E | N | RE 07/05/2020 |
55 | REFACTO AF | FACTEUR VIII | 1000 UI | POUDRE P PREPARATION INJECTABLE | b/1fl+ seringue | PFIZER Europe MA EEIG | V | N | TRANSFERT DU 07/05/2020 |
56 | REFACTO AF | FACTEUR VIII | 500 UI | POUDRE P PREPARATION INJECTABLE | b/1fl+ seringue | PFIZER Europe MA EEIG | V | N | TRANSFERT DU 07/05/2020 |
57 | REFACTO AF | FACTEUR VIII | 250 UI | POUDRE P PREPARATION INJECTABLE | b/1fl+ seringue | PFIZER Europe MA EEIG | V | N | TRANSFERT DU 07/05/2020 |
58 | FORXIGA | DAPAGLIFLOZINE | 5 MG | COMPRIME | B/28 | ASTRA ZENECA | E | N | RE du 08/05/2020 |
59 | FORXIGA | DAPAGLIFLOZINE | 10 MG | COMPRIME | B/28 | ASTRA ZENECA | E | N | RE du 08/05/2020 |
60 | JANUVIA | SITAGLIPTINE | 100 MG | COMPPRIME | B/28 | MSD PAYS BAS | E | N | TRANSFERT DU 08/05/2020 |
61 | REDEX | TADALAFIL | 5 MG | COMPRIME | B/28 | ATTAQADDOM JORDANIE | C | N | RE 12/05/2020 |
62 | REDEX | TADALAFIL | 10MG | COMPRIME | B/2 | ATTAQADDOM JORDANIE | C | N | RE 12/05/2020 |
63 | REDEX | TADALAFIL | 75MG | COMPRIME | B/2 | ATTAQADDOM JORDANIE | C | N | RE 12/05/2020 |
64 | MERIONAL HG | GONODOTROPHINE MENOPAUSIQUE HUMAINE | 150 UI/ML | POUDRE P PREPARATION INJECTABLE | B/1FL+AP DE SOLVANT | IBSA BIOCHIMIQUE SA SUISSE | E | N | RE du 26/05/2020 |
65 | MERIONAL HG | GONODOTROPHINE MENOPAUSIQUE HUMAINE | 75 UI/ML | POUDRE P PREPARATION INJECTABLE | B/1FL+AP DE SOLVANT | IBSA BIOCHIMIQUE SA SUISSE | E | N | RE du 26/05/2020 |